← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
VanHimbergen Robert M
Chief Financial Officer
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001724169
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 2
- Purchases · 24M
- 3
- Average purchase
- $104.3K
- Median purchase
- $96.9K
- Gross purchase value
- $313.0K
Companies: Elanco Animal Health Inc | Hillenbrand, Inc.
3 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-08-10 | Elanco Animal Health Inc | ELAN | Chief Financial Officer | $96.9K | Open filing |
| 2025-12-15 | Elanco Animal Health Inc | ELAN | Chief Financial Officer | $150.4K | Open filing |
| 2025-02-10 | Hillenbrand, Inc. | HI | Chief Financial Officer | $65.7K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small Sample | 66.7% (2/3) | 100.0% (2/2) | +3.9% | +3.9% | +1.9% |
| 20D | 2Small Sample | 66.7% (2/3) | 100.0% (2/2) | +9.7% | +9.7% | +8.5% |
| 60D | 1Small Sample | 50.0% (1/2) | 100.0% (1/1) | +8.1% | +8.1% | +8.1% |
| 120D | 1Small Sample | 50.0% (1/2) | 100.0% (1/1) | +4.0% | +4.0% | +4.0% |
Research patterns
- First purchase in 12M
- 1/2
- Large purchase ≥ $100k
- 1/3
- Cluster buying · 15D
- 3/3
- Buying the dip
- 0/2
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.